AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8877012 — intervention group
Group type: COMPARATOR
Intervention: Control (local radiotherapy without tamoxifen)
Number of subjects: 1716
Study 2065412 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 micrograms of fentanyl with 8 ml preservative‐free normal saline
Number of subjects: 40
Study 2065412 — intervention group
Group type: COMPARATOR
Intervention: 10 ml of preservative‐free normal saline via the epidural catheter
Number of subjects: 40
Study 6371525 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive instrument for acute cardiac ischemia diagnosis
Number of subjects: 2320
Study 6371525 — intervention group
Group type: COMPARATOR
Intervention: Standard diagnostic practices without the predictive instrument
Number of subjects: 2320
Study 28151019 — intervention group
Group type: EXPERIMENTAL
Intervention: SNAP Program
Number of subjects: 252
Study 28151019 — intervention group
Group type: COMPARATOR
Intervention: Standard services
Number of subjects: 252
Study 29722045 — intervention group
Group type: EXPERIMENTAL
Intervention: Body Project intervention (n = 17) - participants tracked daily diet and activity, attended four weekly group-based sessions
Number of subjects: 32
Study 29722045 — intervention group
Group type: COMPARATOR
Intervention: Standard group (n = 15) - directed to track diet and activity level daily
Number of subjects: 32
Study 26035740 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine capsules (200 mg) plus 10% carbohydrate mouth rinse (CAFF + CMR)
Number of subjects: 8
Study 26035740 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% carbohydrate mouth rinse (CMR)
Number of subjects: 8
Study 26035740 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules and placebo mouth rinse (PLACEBO)
Number of subjects: 8
Study 25310121 — intervention group
Group type: EXPERIMENTAL
Intervention: Mother support groups (MSGs) at 15 health facilities
Number of subjects: 30
Study 25310121 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care
Number of subjects: 30
Study 25310121 — intervention group
Group type: EXPERIMENTAL
Intervention: Mother support groups (MSGs)
Number of subjects: 30
Study 22681723 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil 23 mg/day
Number of subjects: 902
Study 19570066 — intervention group
Group type: EXPERIMENTAL
Intervention: Draw-the-Family Test (DFT) administered to patients with benign anorectal disease
Number of subjects: 62
Study 19570066 — intervention group
Group type: EXPERIMENTAL
Intervention: Draw-the-Family Test (DFT) administered to patients with organic disease
Number of subjects: 62
Study 19570066 — intervention group
Group type: EXPERIMENTAL
Intervention: Draw-the-Family Test (DFT) administered to patients who failed treatment
Number of subjects: 62
Study 19570066 — intervention group
Group type: COMPARATOR
Intervention: Draw-the-Family Test (DFT) administered to healthy control subjects
Number of subjects: 62
Study 16644036 — intervention group
Group type: COMPARATOR
Intervention: Protocol A (step-up energy protocol): (1) 200 J anteroapical, (2) 360 J anteroapical, (3) 360 J anteroposterior
Number of subjects: 261
Study 16644036 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol B (high initial energy shock protocol): (1) 360 J anteroapical, (2) 360 J anteroposterior, (3) 360 J posteroanterior
Number of subjects: 261
Study 17095947 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium-selenite (1000 microg as a 30-min bolus injection, followed by 14 daily continuous infusions of 1000 microg intravenously)
Number of subjects: 238
Study 17095947 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium-selenite
Number of subjects: 238
Study 17095947 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 238
Study 14985680 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (4 g/day, 56% DHA and 28% EPA)
Number of subjects: 83
Study 10837185 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyrimethamine plus sulfadoxine (PM/SD)
Number of subjects: 0
Study 10837185 — intervention group
Group type: COMPARATOR
Intervention: Chlorproguanil/dapsone (CPG/Dap)
Number of subjects: 0
Study 9049571 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 605
Study 9049571 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 605
Study 8211620 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (Group V)
Number of subjects: 100
Study 8211620 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional cholecystectomy + injection of 20 ml bupivacaine 0.5% into the mesentery root (Group II)
Number of subjects: 100
Study 8211620 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional cholecystectomy + 7.5 mg propranolol i.v. and 0.5 mg neostigmine s.c. (Group III)
Number of subjects: 100
Study 8211620 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional cholecystectomy + bupivacaine + propranolol and neostigmine (Group IV)
Number of subjects: 100
Study 8211620 — intervention group
Group type: COMPARATOR
Intervention: Conventional cholecystectomy (Control Group)
Number of subjects: 100
Study 2947723 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangdu pellet
Number of subjects: 25
Study 2947723 — intervention group
Group type: COMPARATOR
Intervention: Control group (16 cases)
Number of subjects: 25
Study 11323442 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase Fruit and Vegetable intake
Number of subjects: 0
Study 11323442 — intervention group
Group type: COMPARATOR
Intervention: Decrease high-fat/high-sugar intake
Number of subjects: 0
Study 31243641 — intervention group
Group type: EXPERIMENTAL
Intervention: Macuprev® supplementation (two tablets/day for 6 months)
Number of subjects: 30
Study 31243641 — intervention group
Group type: COMPARATOR
Intervention: Placebo (two tablets/day for 6 months)
Number of subjects: 30
Study 30042488 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MED)
Number of subjects: 144
Study 30042488 — intervention group
Group type: EXPERIMENTAL
Intervention: Central European diet (CED)
Number of subjects: 144
Study 30042488 — intervention group
Group type: EXPERIMENTAL
Intervention: More adherent participants in both diet groups
Number of subjects: 144
Study 30042488 — intervention group
Group type: EXPERIMENTAL
Intervention: More adherent participants in CED
Number of subjects: 144
Study 30042488 — intervention group
Group type: EXPERIMENTAL
Intervention: Both diets (CED and MED)
Number of subjects: 144
Study 26632030 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart transplantation after listing for heart transplantation
Number of subjects: 555
Study 26632030 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with listing for heart transplantation
Number of subjects: 555
Study 26632030 — intervention group
Group type: COMPARATOR
Intervention: Post-Norwood procedure care
Number of subjects: 555
Study 24903630 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild-moderate endurance exercise (20-min submaximal cycling at ≈45 Watts)
Number of subjects: 26
Study 22624251 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiographic method for PLC isometric point
Number of subjects: 20
Study 22624251 — intervention group
Group type: COMPARATOR
Intervention: Anatomic method for PLC isometric point
Number of subjects: 20
Study 22624251 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiographic method for posteromedial side
Number of subjects: 20
Study 22624251 — intervention group
Group type: COMPARATOR
Intervention: Anatomic method for posteromedial side
Number of subjects: 20
Study 20203367 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (200 mg p/o from the preoperative day till the 7th postoperative day)
Number of subjects: 32
Study 20203367 — intervention group
Group type: COMPARATOR
Intervention: Control group (no vitamin E treatment)
Number of subjects: 32
Study 17395046 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (RT) for 11 weeks (n = 7)
Number of subjects: 13
Study 17395046 — intervention group
Group type: COMPARATOR
Intervention: Usual care (C) for 11 weeks (n = 6)
Number of subjects: 13
Study 16190847 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard TURP
Number of subjects: 161
Study 16190847 — intervention group
Group type: COMPARATOR
Intervention: Prostatic hemiresection
Number of subjects: 161
Study 16190847 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 161
Study 12189059 — intervention group
Group type: COMPARATOR
Intervention: Placebo-controlled trials
Number of subjects: 0
Study 12189059 — intervention group
Group type: COMPARATOR
Intervention: Proven effective treatment
Number of subjects: 0
Study 11737326 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate antiretroviral treatment (zidovudine)
Number of subjects: 133
Study 11737326 — intervention group
Group type: COMPARATOR
Intervention: Deferred antiretroviral treatment (placebo)
Number of subjects: 133
Study 11737326 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall trial experience
Number of subjects: 133
Study 7503048 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic Blood Pressure (SBP)
Number of subjects: 19698
Study 7503048 — intervention group
Group type: EXPERIMENTAL
Intervention: Diastolic Blood Pressure (DBP)
Number of subjects: 19698
Study 7503048 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment
Number of subjects: 19698
Study 7503048 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper 40% of SBP distribution
Number of subjects: 19698
Study 1967416 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based bicycle exercise training
Number of subjects: 11
Study 1967416 — intervention group
Group type: COMPARATOR
Intervention: Activity restriction (rest)
Number of subjects: 11
Study 365795 — intervention group
Group type: EXPERIMENTAL
Intervention: Viminol (70 mg)
Number of subjects: 41
Study 365795 — intervention group
Group type: EXPERIMENTAL
Intervention: Viminol (70 mg) combined with chlordiazepoxide (10 mg)
Number of subjects: 41
Study 365795 — intervention group
Group type: COMPARATOR
Intervention: Chlordiazepoxide (10 mg)
Number of subjects: 41
Study 30213641 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective information (incomplete/biased toward repeat caesarean) and relative risk formats (e.g., 2.5 times higher)
Number of subjects: 669
Study 30213641 — intervention group
Group type: COMPARATOR
Intervention: Non-selective information (complete/unbiased) and absolute risk formats (e.g., 0.01 per 100)
Number of subjects: 669
Study 30408717 — intervention group
Group type: EXPERIMENTAL
Intervention: LCHF diet (less than 20g carbohydrates per day)
Number of subjects: 30
Study 30408717 — intervention group
Group type: EXPERIMENTAL
Intervention: LCHF diet
Number of subjects: 30
Study 30408717 — intervention group
Group type: COMPARATOR
Intervention: Control group (habitual diet ad libitum)
Number of subjects: 30
Study 26482893 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild hypoxia at 12,000 ft
Number of subjects: 36
Study 26482893 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing 100% oxygen after mild hypoxia
Number of subjects: 36
Study 26482893 — intervention group
Group type: COMPARATOR
Intervention: Mild hypoxia at 8000 ft
Number of subjects: 36
Study 24571621 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified assertive intervention based on the international assertive community treatment model
Number of subjects: 29
Study 24571621 — intervention group
Group type: COMPARATOR
Intervention: Standard care according to the model of service delivery in this region
Number of subjects: 29
Study 22207490 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl (FE, 1-2 μg/kg)
Number of subjects: 150
Study 22207490 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensorial saturation (SS)
Number of subjects: 150
Study 22207490 — intervention group
Group type: COMPARATOR
Intervention: Facilitated tucking (FT)
Number of subjects: 150
Study 20100959 — intervention group
Group type: EXPERIMENTAL
Intervention: PROSTVAC-VF plus granulocyte-macrophage colony-stimulating factor
Number of subjects: 125
Study 20100959 — intervention group
Group type: COMPARATOR
Intervention: Control empty vectors plus saline injections
Number of subjects: 125
Study 20100959 — intervention group
Group type: EXPERIMENTAL
Intervention: PROSTVAC-VF
Number of subjects: 125
Study 17331667 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-dimensional conformal radiotherapy (3D-CRT)
Number of subjects: 268
Study 16279894 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid injection (0.5 cc/quadrant triamcinolone 40 mg/cc)
Number of subjects: 30
Study 16279894 — intervention group
Group type: COMPARATOR
Intervention: Sham injection
Number of subjects: 30
Study 12601292 — intervention group
Group type: EXPERIMENTAL
Intervention: Low carbohydrate bar (Atkins Advantage Bar, LC)
Number of subjects: 20
Study 12601292 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate carbohydrate bar (Balance Bar, MC)
Number of subjects: 20
Study 12601292 — intervention group
Group type: EXPERIMENTAL
Intervention: High carbohydrate bar (Power Bar, HC)
Number of subjects: 20
Study 12601292 — intervention group
Group type: EXPERIMENTAL
Intervention: Chicken breast (CHI)
Number of subjects: 20
Study 12601292 — intervention group
Group type: COMPARATOR
Intervention: White bread (WB)
Number of subjects: 20
Study 10972455 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative mood condition (distressing or depressing Mood Induction Procedure)
Number of subjects: 40
Study 10972455 — intervention group
Group type: COMPARATOR
Intervention: Neutral mood condition (control)
Number of subjects: 40
Study 10972455 — intervention group
Group type: EXPERIMENTAL
Intervention: All conditions (following exposure to alcohol cue)
Number of subjects: 40
Study 10162773 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian statistics
Number of subjects: 0
Study 10162773 — intervention group
Group type: COMPARATOR
Intervention: Frequentist statistics
Number of subjects: 0
Study 10162773 — intervention group
Group type: COMPARATOR
Intervention: Historical controls
Number of subjects: 0
Study 10162773 — intervention group
Group type: COMPARATOR
Intervention: Patient choice and autonomy
Number of subjects: 0
Study 10162773 — intervention group
Group type: EXPERIMENTAL
Intervention: Good statistical techniques
Number of subjects: 0
Study 2050230 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical retinoic acid 0.01%, 0.025%, or 0.05% applied for 10 days
Number of subjects: 0
Study 2050230 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of triamcinolone acetonide 0.1% and retinoic acid 0.025%
Number of subjects: 0
Study 2050230 — intervention group
Group type: COMPARATOR
Intervention: Triamcinolone acetonide 0.1% alone
Number of subjects: 0
Study 6342544 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment of salbutamol (inhalational powder and tablets)
Number of subjects: 18
Study 6342544 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablet treatment of salbutamol
Number of subjects: 18
Study 6342544 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalational powder treatment of salbutamol
Number of subjects: 18
Study 6342544 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment of salbutamol
Number of subjects: 18
Study 6342544 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined or tablet treatment of salbutamol
Number of subjects: 18
Study 29401114 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise training for 12 weeks
Number of subjects: 18
Study 29401114 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 18
Study 27434745 — intervention group
Group type: EXPERIMENTAL
Intervention: Normobaric hypoxia (2600m)
Number of subjects: 36
Study 24743971 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic saline
Number of subjects: 30
Study 24743971 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline
Number of subjects: 30
Study 22234381 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg of risperidone
Number of subjects: 12
Study 22234381 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg of risperidone
Number of subjects: 12
Study 22234381 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 21143864 — intervention group
Group type: EXPERIMENTAL
Intervention: Program of rehabilitative exercise and education (PREVENT)
Number of subjects: 250
Study 21143864 — intervention group
Group type: COMPARATOR
Intervention: Usual care (USUAL CARE)
Number of subjects: 250
Study 17413949 — intervention group
Group type: EXPERIMENTAL
Intervention: Linoleic acid (28.5 mg) and gamma-linolenic acid (15 mg) once daily
Number of subjects: 57
Study 17413949 — intervention group
Group type: COMPARATOR
Intervention: Eyelid hygiene once daily
Number of subjects: 57
Study 17413949 — intervention group
Group type: EXPERIMENTAL
Intervention: Both linoleic acid and eyelid hygiene
Number of subjects: 57
Study 15677576 — intervention group
Group type: EXPERIMENTAL
Intervention: PHQ-9 score > or =10
Number of subjects: 316
Study 15677576 — intervention group
Group type: EXPERIMENTAL
Intervention: PHQ-9
Number of subjects: 316
Study 12406263 — intervention group
Group type: EXPERIMENTAL
Intervention: Practical skills tutorial in Year 3 (3-hour session on injection and suturing techniques)
Number of subjects: 185
Study 12406263 — intervention group
Group type: COMPARATOR
Intervention: Control group (no tutorial)
Number of subjects: 185
Study 9612217 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril therapy
Number of subjects: 27
Study 9612217 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 8160532 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsatile measurement of plasma GnRH
Number of subjects: 25
Study 8160532 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsatile measurement of plasma CRF
Number of subjects: 25
Study 8160532 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation analysis of GnRH and CRF pulses
Number of subjects: 25
Study 3281211 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized phase III protocol for advanced soft-tissue sarcoma
Number of subjects: 750
Study 3281211 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved surgical techniques for extremity sarcomas
Number of subjects: 750
Study 3281211 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic metastasis management
Number of subjects: 750
Study 30180918 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin (36 IU BID, supervised administration 45 min prior to CBSST sessions)
Number of subjects: 62
Study 30180918 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Social Skills Training (CBSST)
Number of subjects: 62
Study 30180918 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 29609999 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% Benzoyl Peroxide (BPO)
Number of subjects: 40
Study 29609999 — intervention group
Group type: COMPARATOR
Intervention: 4% Chlorhexidine Soap (CHS)
Number of subjects: 40
Study 26874557 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 300 μg oral premedication administered 90 minutes before surgery
Number of subjects: 30
Study 26874557 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 24444140 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief psychodynamic psychotherapy (eight sessions administered at two-week intervals)
Number of subjects: 33
Study 24444140 — intervention group
Group type: COMPARATOR
Intervention: Usual care (clinical interview, neurological examination, counselling, symptomatic therapy)
Number of subjects: 33
Study 22468627 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate release (IR) sodium nitrite
Number of subjects: 12
Study 22468627 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteric-coated (EC) sodium nitrite
Number of subjects: 12
Study 20305040 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.02% BAC
Number of subjects: 32
Study 20305040 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% BAC
Number of subjects: 32
Study 20305040 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.08% BAC
Number of subjects: 32
Study 20305040 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.10% BAC
Number of subjects: 32
Study 20305040 — intervention group
Group type: EXPERIMENTAL
Intervention: Active auditory oddball
Number of subjects: 32
Study 20305040 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive auditory oddball
Number of subjects: 32
Study 20305040 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-task condition
Number of subjects: 32
Study 20305040 — intervention group
Group type: COMPARATOR
Intervention: Control (0.00% BAC)
Number of subjects: 32
Study 17056220 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% N-chlorotaurine (NCT) solution, local irrigations once daily until the canal was dry
Number of subjects: 10
Study 17056220 — intervention group
Group type: COMPARATOR
Intervention: Standard postoperative procedure (control group)
Number of subjects: 10
Study 16331769 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical diclofenac diethylamine gel, 1.16%, 4 g applied qid for 3 weeks
Number of subjects: 238
Study 16331769 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 238
Study 11964340 — intervention group
Group type: EXPERIMENTAL
Intervention: Training package of four half days on brief cognitive behaviour therapy
Number of subjects: 272
Study 11964340 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 272
Study 9609775 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous negative-pressure breathing (CNPB)
Number of subjects: 7
Study 9609775 — intervention group
Group type: COMPARATOR
Intervention: Control condition (without CNPB)
Number of subjects: 7
Study 8008822 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass-ionomer cement
Number of subjects: 45
Study 8008822 — intervention group
Group type: COMPARATOR
Intervention: Zinc phosphate cement
Number of subjects: 45
Study 2499178 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy plus intradermal immunization with viral oncolysate (VO)
Number of subjects: 75
Study 2499178 — intervention group
Group type: COMPARATOR
Intervention: Radiation therapy (RT) alone
Number of subjects: 75
Study 1138642 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 300
Study 1138642 — intervention group
Group type: COMPARATOR
Intervention: Low-dose heparin
Number of subjects: 300
Study 1138642 — intervention group
Group type: COMPARATOR
Intervention: Combination of low-dose heparin and hydrocortisone
Number of subjects: 300
Study 7378674 — intervention group
Group type: EXPERIMENTAL
Intervention: Iotroxamide infusion at rates of 0.525 to 6.3 mg/kg/min
Number of subjects: 24